DoW Tuberous Sclerosis Complex, Clinical Translational Research Award
Grant Opportunity Analysis
The Department of the Army through USAMRAA is funding the FY26 Tuberous Sclerosis Complex Research Program Clinical Translational Research Award to advance promising research on tuberous sclerosis complex toward clinical use in diagnosis, prognosis, or treatment. The award supports preclinical and clinical studies, including pilot clinical trials and analyses of real-world data, with a focus on projects that can translate findings into practice. Applications may use multiple principal investigators, and review emphasizes clinical translational potential, impact, research strategy, feasibility, rationale, and personnel, along with data sharing and sex as a biological variable. The program offers $3.5 million total, expects two awards, and requires a pre-application by July 23, 2026, followed by a full application by August 6, 2026, with submissions through eBRAP and/or Grants.gov and questions directed to the eBRAP Help Desk.